"The conference on Molecular Analysis for Personalised Therapy (MAP), now in its 3rd year, is a high-level scientific meeting that explores ways to better use existing research data in order to improve clinical oncologists’ personalised treatment programmes for cancer patients.

It is a joint initiative of ESMO, UNICANCER and Cancer Research UK. This conference shines a light on the latest medical developments in a constantly evolving field.  

Medical oncologists, interns, academics, regulators, industry R&D reps and investigators are invited to register for this important gathering to discuss clinical interpretation of molecular tests for metastatic cancers.

Among topics to be discussed:

• ​​​Macroevolution and impact on treatment resistance
• New models and technologies for personalised medicine
• Personalised medicine applied to immunotherapeutics
• Therapeutic targets in cancer
• Treatment advances in central nervous system tumours
• Tumour microenvironment and treatment resistance
• Understanding the broader tumour microenvironment
• What’s new in the field of clinical trials?